Latest Articles
Single-cell RNA sequencing identifies the prolactin receptor as a therapeutic target in adenomyosis - Nature
Single-cell RNA sequencing identifies the prolactin receptor as a therapeutic target in adenomyosis Nature
Published: Aug. 13, 2025, 2:22 p.m.
New therapeutic targets for endometriosis predicted through Mendelian randomization analysis and case-control trials - Frontiers
New therapeutic targets for endometriosis predicted through Mendelian randomization analysis and case-control trials Frontiers
Published: Aug. 4, 2025, 8:01 a.m.
MRGPRX2 served as a therapeutic target for endometriosis‐induced... - researchgate.net
MRGPRX2 served as a therapeutic target for endometriosis‐induced... researchgate.net
Published: July 7, 2025, 12:30 a.m.
Exosomal miR-92a-3p serves as a promising marker and potential therapeutic target for adenomyosis - Nature.com
Exosomal miR-92a-3p serves as a promising marker and potential therapeutic target for adenomyosis Nature.com
Published: March 22, 2025, 10:22 a.m.
Study reveals potential therapeutic target for endometriosis - MSN
Study reveals potential therapeutic target for endometriosis MSN
Published: Feb. 12, 2025, 5:16 p.m.
Study reveals potential therapeutic target for endometriosis - Medical Xpress
Study reveals potential therapeutic target for endometriosis Medical Xpress
Published: Feb. 12, 2025, 3:26 p.m.
Hong Kong unveils novel therapeutic targets and drug repurposing opportunities for endometriosis - BSA bureau
Hong Kong unveils novel therapeutic targets and drug repurposing opportunities for endometriosis BSA bureau
Published: Jan. 14, 2025, 2:14 p.m.
Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma - Nature.com
Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma Nature.com
Published: Jan. 6, 2025, 7:50 a.m.
Apolipoprotein-B mRNA-editing complex 3B could be a new potential therapeutic target in endometriosis - Nature.com
Apolipoprotein-B mRNA-editing complex 3B could be a new potential therapeutic target in endometriosis Nature.com
Published: Oct. 23, 2024, 4:55 a.m.
Link copied to clipboard!